Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.048 | 0.4 |
mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.042 | 0.4 |
mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.04 | 0.5 |
mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.033 | 0.6 |
mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.025 | 0.6 |
mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.025 | 0.6 |
mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.016 | 0.8 |
mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.01 | 0.8 |